1. Home
  2. CETX vs VRAX Comparison

CETX vs VRAX Comparison

Compare CETX & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$2.87

Market Cap

3.5M

Sector

Technology

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.37

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
VRAX
Founded
1998
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
2.9M
IPO Year
1998
2022

Fundamental Metrics

Financial Performance
Metric
CETX
VRAX
Price
$2.87
$0.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
8.6M
507.2K
Earning Date
02-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,488,088.00
$2,986.00
Revenue This Year
$19.77
$217,274.83
Revenue Next Year
$15.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.39
N/A
52 Week Low
$2.10
$0.31
52 Week High
$49.10
$2.73

Technical Indicators

Market Signals
Indicator
CETX
VRAX
Relative Strength Index (RSI) 49.29 44.24
Support Level $2.49 $0.33
Resistance Level $2.83 $0.44
Average True Range (ATR) 0.36 0.05
MACD 0.07 0.01
Stochastic Oscillator 59.37 32.28

Price Performance

Historical Comparison
CETX
VRAX

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: